SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    S. A. Morgan, E. L. McCabe, L. L. Gathercole, Z. K. Hassan-Smith, D. P. Larner, I. J. Bujalska, P. M. Stewart, J. W. Tomlinson, G. G. Lavery, 11 -HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess, Proceedings of the National Academy of Sciences, 2014, 111, 24, E2482

    CrossRef

  2. 2
    Michael E. Hyland, Ben Whalley, Rupert C. Jones, Matthew Masoli, A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scales, Quality of Life Research, 2014,

    CrossRef

  3. 3
    Emil Sundstrup, Markus D. Jakobsen, Mikkel Brandt, Kenneth Jay, Juan Carlos Colado, Yuling Wang, Lars L. Andersen, Acute Effect of Topical Menthol on Chronic Pain in Slaughterhouse Workers with Carpal Tunnel Syndrome: Triple-Blind, Randomized Placebo-Controlled Trial, Rehabilitation Research and Practice, 2014, 2014, 1

    CrossRef

  4. 4
    A. Kavanaugh, A. F. Wells, Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis, Rheumatology, 2014, 53, 10, 1742

    CrossRef

  5. 5
    Matthew P. Schreiber, Elizabeth Colantuoni, Oscar J. Bienvenu, Karin J. Neufeld, Kuan-Fu Chen, Carl Shanholtz, Pedro A. Mendez-Tellez, Dale M. Needham, Corticosteroids and Transition to Delirium in Patients With Acute Lung Injury*, Critical Care Medicine, 2014, 42, 6, 1480

    CrossRef

  6. 6
    George Triadafilopoulos, Glucocorticoid therapy for gastrointestinal diseases, Expert Opinion on Drug Safety, 2014, 13, 5, 563

    CrossRef

  7. 7
    Suk-young Lee, Naoki Kurita, Yasuhisa Yokoyama, Masanori Seki, Yuichi Hasegawa, Yasushi Okoshi, Shigeru Chiba, Glucocorticoid-induced diabetes mellitus in patients with lymphoma treated with CHOP chemotherapy, Supportive Care in Cancer, 2014, 22, 5, 1385

    CrossRef

  8. 8
    M Iudici, B Russo, M Mitidieri, G Cuomo, G Valentini, Glucocorticoids in systemic sclerosis: patients’ beliefs and treatment adherence, Scandinavian Journal of Rheumatology, 2014, 1

    CrossRef

  9. 9
    Kawtar Nassar, Saadia Janani, Christian Roux, Wafaa Rachidi, Noufissa Etaouil, Ouafaa Mkinsi, La corticothérapie systémique au long cours : représentations des patients, perceptions des prescripteurs et observance thérapeutique, Revue du Rhumatisme, 2014, 81, 1, 49

    CrossRef

  10. 10
    Kawtar Nassar, Saadia Janani, Christian Roux, Wafae Rachidi, Noufissa Etaouil, Ouafaa Mkinsi, Long-term systemic glucocorticoid therapy: Patients’ representations, prescribers’ perceptions, and treatment adherence, Joint Bone Spine, 2014, 81, 1, 64

    CrossRef

  11. 11
    Ezra Hahn, Normand Laperriere, Barbara-Ann Millar, James Oestreicher, Hugh McGowan, Hatem Krema, Harmeet Gill, Dan DeAngelis, Jeff Hurwitz, Nancy Tucker, Rand Simpson, Caroline Chung, Orbital radiation therapy for Graves’ ophthalmopathy: Measuring clinical efficacy and impact, Practical Radiation Oncology, 2014, 4, 4, 233

    CrossRef

  12. 12
    You Ra Kim, Wan Seok Kang, Eui Yong Kweon, Nam Chun Cho, Dong Wook Lee, Steroid-Induced Ocular Hypertension Model in the Mice, Journal of the Korean Ophthalmological Society, 2014, 55, 8, 1202

    CrossRef

  13. 13
    Laurence Fardet, Bruno Fève, Systemic Glucocorticoid Therapy: a Review of its Metabolic and Cardiovascular Adverse Events, Drugs, 2014, 74, 15, 1731

    CrossRef

  14. 14
    Niels Eckstein, Bodo Haas, Moritz Hass, Vladlena Pfeifer, Systemic therapy of Cushing’s syndrome, Orphanet Journal of Rare Diseases, 2014, 9, 1, 122

    CrossRef

  15. 15
    L. Fardet, Complications de la corticothérapie chez les patients souffrant de maladie de Horton ou de pseudopolyarthrite rhizomélique, La Revue de Médecine Interne, 2013, 34, 7, 438

    CrossRef

  16. 16
    A. Simon, A.-M. Ané, A. Afroun, Corticoïdes et éducation thérapeutique : expérience d’un service de médecine interne, La Revue de Médecine Interne, 2013, 34, 5, 287

    CrossRef

  17. 17
    O. Grossi, T. Généreau, Corticoïdes et… infections, dopage, chirurgie et sexualité, La Revue de Médecine Interne, 2013, 34, 5, 269

    CrossRef

  18. 18
    M. Pineton de Chambrun, B. Wechsler, D. Saadoun, Corticoterapia, EMC - Tratado de Medicina, 2013, 17, 3, 1

    CrossRef

  19. 19
    L. Sailler, G. Pugnet, P. Arlet, Corticothérapie systémique : les mesures d’accompagnement, La Revue de Médecine Interne, 2013, 34, 5, 279

    CrossRef

  20. 20
    L. Fardet, Effets indésirables métaboliques et cardiovasculaires des corticothérapies systémiques, La Revue de Médecine Interne, 2013, 34, 5, 303

    CrossRef

  21. 21
    L. Fardet, Effets métaboliques des hypercorticismes exogènes, Obésité, 2013, 8, 3, 160

    CrossRef

  22. 22
    N. Colliou, D. Picard, F. Caillot, S. Calbo, S. Le Corre, A. Lim, B. Lemercier, B. Le Mauff, M. Maho-Vaillant, S. Jacquot, C. Bedane, P. Bernard, F. Caux, C. Prost, E. Delaporte, M.-S. Doutre, B. Dreno, N. Franck, S. Ingen-Housz-Oro, O. Chosidow, C. Pauwels, C. Picard, J.-C. Roujeau, M. Sigal, E. Tancrede-Bohin, I. Templier, R. Eming, M. Hertl, M. D'Incan, P. Joly, P. Musette, Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response, Science Translational Medicine, 2013, 5, 175, 175ra30

    CrossRef

  23. 23
    Gert-Jan Braunstahl, Jan Chlumský, Guy Peachey, Chien-Wei Chen, Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting, Allergy, Asthma & Clinical Immunology, 2013, 9, 1, 47

    CrossRef

  24. 24
    Shinichiro Morishita, Katsuji Kaida, Shinya Yamauchi, Koichiro Sota, Shinichi Ishii, Kazuhiro Ikegame, Norihiko Kodama, Hiroyasu Ogawa, Kazuhisa Domen, Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients, Supportive Care in Cancer, 2013, 21, 8, 2161

    CrossRef

  25. 25
    L. Fardet, C. Vigouroux, J. Capeau, Syndromes lipodystrophiques, La Revue de Médecine Interne, 2013, 34, 10, 614

    CrossRef

  26. 26
    A. Ricoux, M. Guitteny-Collas, A. Sauvaget, P. Delvot, P. Pottier, M. Hamidou, J.-M. Vanelle, Troubles psychiatriques induits par la corticothérapie orale : mise au point sur la nature, l’incidence, les facteurs de risque et le traitement, La Revue de Médecine Interne, 2013, 34, 5, 293

    CrossRef

  27. 27
    Kyriakos A. Kirou, Dimitrios T. Boumpas, Dubois' Lupus Erythematosus and Related Syndromes, 2013,

    CrossRef

  28. 28
    C. Vanhaecke Collard, M. Dramé, J.-L. Novella, F. Blanchard, J.-L. Pennaforte, R. Mahmoudi, Manifestations fonctionnelles associées à la prise de corticoïdes chez les sujets âgés, La Revue de Médecine Interne, 2012, 33, 7, 358

    CrossRef

  29. 29
    F.E. Lamchahab, W. Reffas, T. Bouattar, E.K. Abdellaoui, N. Ouzeddoun, R. Bayahia, A. Aouni, T. El Fassi Fihri, K. Senouci, M. Ait Ourhroui, B. Hassam, Mesures adjuvantes à une corticothérapie systémique prolongée : que faut-il prescrire ?, Annales Pharmaceutiques Françaises, 2012, 70, 5, 292

    CrossRef

  30. 30
    Tali-Anne Szwebel, Claire Le Jeunne, Risques cardiovasculaires d’une corticothérapie, La Presse Médicale, 2012, 41, 4, 384

    CrossRef

  31. 31
    Marc Michel, Odile Beyne Rauzy, Francoise Roudot Thoraval, Laetitia Languille, Mehdi Khellaf, Philippe Bierling, Bertrand Godeau, Characteristics and outcome of immune thrombocytopenia in elderly: Results from a single center case-controlled study, American Journal of Hematology, 2011, 86, 12
  32. 32
    Evelyn Sarnes, Leslie Crofford, Maria Watson, Greg Dennis, Hong Kan, Damon Bass, Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review, Clinical Therapeutics, 2011, 33, 10, 1413

    CrossRef

  33. 33
    J. Grangé, C. Tesmoingt, M.-P. Chauveheid, M. Vitse, L. Kompf, M.-J. Kermel, A. Certain, P. Arnaud, T. Papo, Mise en place d’un programme d’éducation thérapeutique des patients traités par corticoïdes dans un service de médecine interne, Le Pharmacien Hospitalier et Clinicien, 2011, 46, 2, 81

    CrossRef

  34. 34
    L. Fardet, I. Petersen, I. Nazareth, Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years, Rheumatology, 2011, 50, 11, 1982

    CrossRef

  35. 35
    David M. Poetker, Douglas D. Reh, A Comprehensive Review of the Adverse Effects of Systemic Corticosteroids, Otolaryngologic Clinics of North America, 2010, 43, 4, 753

    CrossRef

  36. 36
    C. Arena, A.-S. Morin, T. Blanchon, T. Hanslik, J. Cabane, A. Dupuy, L. Fardet, Impact of glucocorticoid-induced adverse events on adherence in patients receiving long-term systemic glucocorticoid therapy, British Journal of Dermatology, 2010, 163, 4
  37. 37
    Weedon's Skin Pathology, 2010,

    CrossRef

  38. 38
    J. Costa, M. Farré, Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions, 2010,

    CrossRef

  39. 39
    Lesley A. Graff, John R. Walker, Charles N. Bernstein, Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management, Inflammatory Bowel Diseases, 2009, 15, 7
  40. 40
    L. Fardet, A. Kettaneh, J. Gérol, C. Tolédano, K.-P. Tiev, J. Cabane, Effet à court terme des apports sodés sur la pression artérielle des patients recevant une corticothérapie systémique : étude prospective, randomisée, croisée, La Revue de Médecine Interne, 2009, 30, 9, 741

    CrossRef

  41. 41
    Gottfried Lemperle, Nelly Gauthier-Hazan, Foreign Body Granulomas after All Injectable Dermal Fillers: Part 2. Treatment Options, Plastic and Reconstructive Surgery, 2009, 123, 6, 1864

    CrossRef

  42. 42
    Thomas H. Mader, Robert P. Werner, David G. Chamberlain, Debra Doornbos, Giant cell arteritis in Alaska Natives, Canadian Journal of Ophthalmology / Journal Canadien d'Ophtalmologie, 2009, 44, 1, 53

    CrossRef

  43. 43
    B. Goichot, L’interniste iatrogène : l’exemple de la corticothérapie, La Revue de Médecine Interne, 2009, 30, S299

    CrossRef

  44. 44
    A. Perdoncini-Roux, T. Blanchon, T. Hanslik, A. Lasserre, C. Turbelin, Y. Dorleans, J. Cabane, L. Fardet, Perception par les médecins généralistes de la gêne induite par les effets indésirables d’une corticothérapie systémique prolongée, Revue d'Épidémiologie et de Santé Publique, 2009, 57, 2, 93

    CrossRef

  45. 45
    L. Fardet, T. Blanchon, A. Perdoncini-Roux, A. Kettaneh, K. Tiev, C. Turbelin, Y. Dorleans, J. Cabane, T. Hanslik, Perception par les médecins internistes de la fréquence et de la gêne induite par les effets indésirables d’une corticothérapie systémique prolongée, La Revue de Médecine Interne, 2009, 30, 2, 113

    CrossRef

  46. 46
    Patrick W.F. Hadoke, Javaid Iqbal, Brian R. Walker, Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease, British Journal of Pharmacology, 2009, 156, 5
  47. 47
    B.H. Thiers, Corticosteroid-induced clinical adverse events: frequency, risk factors and patien's opinion, Yearbook of Dermatology and Dermatologic Surgery, 2008, 2008, 253

    CrossRef

  48. 48
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2008, 17, 2
  49. 49
    Laurence Fardet, Adrien Kettaneh, Kiet-Phong Tiev, Bénédicte Fabre, Cécile Tolédano, Jean Cabane, Antoine Flahault, Digital photography as an operational tool for assessing corticosteroid-induced lipodystrophy, European Journal of Internal Medicine, 2008, 19, 5, 340

    CrossRef

  50. 50
    Sue Jessop, Nonhlanhla P Khumalo, Pemphigus, American Journal of Clinical Dermatology, 2008, 9, 3, 147

    CrossRef

  51. 51
    Allyson K McDonough, Jeffrey R Curtis, Kenneth G Saag, The epidemiology of glucocorticoid-associated adverse events, Current Opinion in Rheumatology, 2008, 20, 2, 131

    CrossRef

  52. 52
    S. Feldman-Billard, E. Héron, Tolérance systémique des corticoïdes en ophtalmologie : influence de la voie d’administration, Journal Français d'Ophtalmologie, 2008, 31, 10, 1026

    CrossRef

  53. 53
    &NA;, Understanding the underlying mechanisms and incidence of adverse events induced by systemic corticosteroids may improve prevention and management, Drugs & Therapy Perspectives, 2008, 24, 9, 20

    CrossRef

  54. 54
    Laurence Fardet, Abdulrhaman Kassar, Jean Cabane, Antoine Flahault, Corticosteroid-Induced Adverse Events in Adults, Drug Safety, 2007, 30, 10, 861

    CrossRef

  55. 55
    L. Fardet, A. Flahault, A. Kettaneh, K.P. Tiev, C. Tolédano, J. Cabane, Histoire naturelle de la lipodystrophie cervicofaciale cortico-induite: suivi prospectif d'une cohorte de 37 patients, La Revue de Médecine Interne, 2007, 28, 12, 825

    CrossRef

  56. 56
    N. Dupin, Quoi de neuf en dermatologie clinique ?, Annales de Dermatologie et de Vénéréologie, 2007, 134, 8S3

    CrossRef

  57. 57
    C. Paul, Quoi de neuf en thérapeutique ?, Annales de Dermatologie et de Vénéréologie, 2007, 134, 8S64

    CrossRef